The Center for Human Genome Variation (CHGV) was formed in 2005 as a Center within the Duke Institute for Genome Sciences & Policy, and in February 2010 was named an independent Center under the Duke University School of Medicine. Under the direction of Dr. David Goldstein
, the CHGV is undertaking bold projects, with cutting-edge technologies, and a vibrant team of researchers with the goal of changing how genetics informs patient care.
The CHGV is home to the Genomic Analysis Facility, a high throughput genotyping and sequencing facility directed by Dr. Erin Heinzen.
The Center for Human Genome Variation is committed to promoting diversity and inclusion within our faculty, staff, students, and scientific agenda. Consistent with Duke University School of Medicine, we strive to be inclusive of all dimensions of diversity including, but not limited to, age, race, gender, gender identity, sexual orientation, or religion. Please see the link below for additional information about the School of Medicine’s Office of Diversity and Inclusion.